Abstract
The prevalence of alterations of liver function tests in patients treated with a wide range of antypsychotics is unknown. The aim of this study was to analyze the effects of antipsychotics on liver function tests in a population of schizophrenic outpatients. Concentrations of AST, ALT, GGT, alkaline phosphatase, albumin, and bilirubin were determined in 54 patients fitting DSM‐IV criteria of schizophrenia, and the same number of sex‐ and age‐matched healthy subjects. Assessments included the Clinical Global Impression (CGI) and the Positive and Negative Syndrome Scale (PANSS) in addition to treatment related variables. Transaminases concentrations were slightly elevated in study patients compared to healthy controls, but without statistical significance. Alkaline phosphatase showed higher values in schizophrenic patients. Albumin and bilirubin were lower in study patients. Liver function tests abnormalities were found in about 10% of schizophrenic patients treated with antipsychotics. Treatment with depot phenotiazines induces alteration in these tests more frequently than treatment with other antipsychotics. PANSS negative subscale scores directly correlated with alkaline phosphatase and inversely correlated with albumin. A substantial number of patients in treatment with antipsychotic drugs present alterations of liver function tests. Both pharmacological and clinical factors could be related with these alterations. J. Clin. Lab. Anal. 17:216–218, 2003. © 2003 Wiley‐Liss, Inc.
Keywords: liver function tests, schizophrenia, antipsychotics, neuroleptics
REFERENCES
- 1. Derby LE, Pérez Gutthann S, Jick H, Dean AD. Liver disorders in patients receiving chlorpromazine or isoniazid. Pharmacotherapy 1993;13:353–358. [PubMed] [Google Scholar]
- 2. Hansen TE, Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophr Bull 1997;23:567–582. [DOI] [PubMed] [Google Scholar]
- 3. Selim K, Kaplowitz N. Hepatotoxicity of psychotropic drugs. Hepatology 1999;29:1347–1351. [DOI] [PubMed] [Google Scholar]
- 4. Holt RJ. Fluphenazine decanoate‐induced cholestatic jaundice and thrombocytopenia. Pharmacotherapy 1984;4:227–229. [DOI] [PubMed] [Google Scholar]
- 5. American Psychiatric Association . Diagnostic and statistical manual of mental disorders, 4th ed Washington, DC: APA; 1994. [Google Scholar]
- 6. Wing JK, Babor T, Brugha T, et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:589–593. [DOI] [PubMed] [Google Scholar]
- 7. Vázquez‐Barquero JL, Gaite L, Artal J, et al. Desarrollo y Verificación de la Versión Española de la Entrevista Psiquiátrica “Sistema SCAN” (Cuestionarios para la Evaluación Clínica en Neuropsiquiatría). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1994;22:109–120. [PubMed] [Google Scholar]
- 8. Bech P, Malt UF, Dencker SJ, et al. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993;87(suppl 37):30–31. [PubMed] [Google Scholar]
- 9. Kay SR. Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276. [DOI] [PubMed] [Google Scholar]
- 10. Obata T. Intrahepatic cholestasis and hyperbilirubinemia in ethynyl estradiol and chlorpromazine‐treated rats. Gastroenterol Jpn 1983;18:538–548. [DOI] [PubMed] [Google Scholar]
- 11. Cepelak I, Lipovac K, Juretic D, Birek Z. Effects of neuroleptic phenothiazines on the activities of aminotransferases and gamma‐glutamyltransferase in serum and liver. J Clin Chem Clin Biochem 1986;24:583–587. [DOI] [PubMed] [Google Scholar]